Can CYP2C19 help with longevity?

The provided context contains no direct evidence linking CYP2C19 to longevity. CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications such as clopidogrel and proton pump inhibitors. The rapid metabolizer variant (CYP2C19*17) can affect drug efficacy and side effects, but a direct connection to aging or lifespan extension is not supported by the given information. The mention in relation to skincare products is purely mechanistic and lacks human validation. Consumer DNA tests often overstate the clinical relevance of such variants. For evidence-based longevity assessment, factors like diet, exercise, and overall health biomarkers are far more important. The available sources do not provide robust data on this topic.